Globally, the number of diabetes patients is at around half a million with over 30 million in the US alone, the most sought after market for diabetes care companies, especially those into insulin.

Tinkering with the tax rates or tax provisions before the release of the report will lead to avoidable controversies.

During the week, the 30-share Sensex gained 378.77 points, or 1 per cent and the Nifty rose 112 points, or 1.02 per cent.

The whistleblower complaint alleges that an Indian pharmaceutical manufacturer Aditya Medisales Ltd had transactions with Suraksha Realty, controlled by Sun Pharma's co-promoter, Sudhir Valia.

Net profit rose to Rs 1,444 crore for the quarter ended December 2018 compared with Rs 1,326 crore a year earlier.

The stock has been gaining for the last 3 days and has risen 4.26% during the period. It has gained 23.64% during the last one year and risen 2% since the beginning of this year.

While a large upmove from the current Nifty levels of 10887 on Jan 15, 2019 seems unlikely, Nifty can still attempt to rise to 11,200-11,300 levels before correcting. In the process, a lot of stocks and sectors may sequentially undergo upward correction of the recent fall.

D-Mart's biggest edge over other retailers is its strategy of offering merchandise to consumers at a lower MRP.